Decision of the EEA joint Committee No 289/2021 of 29 October 2021 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/537]
Date: 2021-10-29
Institutions: EEA Joint Committee
Subjects: European Economic Area, animal welfare, chemical product, chlorine, decontamination, drinking water, food safety, market approval, revision of an agreement




L_202400537EN.000101.fmx.xml












Official Journal of the European Union


EN
Series L













2024/537


29.2.2024







            DECISION OF THE EEA JOINT COMMITTEE No 289/2021
of 29 October 2021
         
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/537]


THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:







(1)


Commission Implementing Regulation (EU) 2021/345 of 25 February 2021 approving active chlorine generated from sodium chloride by electrolysis as an active substance for use in biocidal products of product types 2, 3, 4 and 5 (1) is to be incorporated into the EEA Agreement.












(2)


Commission Implementing Regulation (EU) 2021/347 of 25 February 2021 approving active chlorine released from hypochlorous acid as an active substance for use in biocidal products of product-types 2, 3, 4 and 5 (2) is to be incorporated into the EEA Agreement.












(3)


Commission Implementing Regulation (EU) 2021/348 of 25 February 2021 approving carbendazim as an existing active substance for use in biocidal products of product-types 7 and 10 (3) is to be incorporated into the EEA Agreement.












(4)


Commission Implementing Decision (EU) 2021/327 of 23 February 2021 postponing the expiry date of approval of metofluthrin for use in biocidal products of product-type 18 (4) is to be incorporated into the EEA Agreement.












(5)


Commission Implementing Decision (EU) 2021/333 of 24 February 2021 postponing the expiry date of approval of alphachloralose for use in biocidal products of product-type 14 (5) is to be incorporated into the EEA Agreement.












(6)


Commission Implementing Decision (EU) 2021/354 of 25 February 2021 postponing the expiry date of approval of propiconazole for use in biocidal products of product-type 8 (6) is to be incorporated into the EEA Agreement.












(7)


Annex II to the EEA Agreement should therefore be amended accordingly,





HAS ADOPTED THIS DECISION:



Article 1
The following points are inserted after point 12zzzzzzu (Commission Implementing Regulation (EU) 2020/1763) of Chapter XV of Annex II to the EEA Agreement:






‘12zzzzzzv.



32021 R 0345: Commission Implementing Regulation (EU) 2021/345 of 25 February 2021 approving active chlorine generated from sodium chloride by electrolysis as an active substance for use in biocidal products of product types 2, 3, 4 and 5 (OJ L 68, 26.2.2021, p. 163).










12zzzzzzw.



32021 R 0347: Commission Implementing Regulation (EU) 2021/347 of 25 February 2021 approving active chlorine released from hypochlorous acid as an active substance for use in biocidal products of product-types 2, 3, 4 and 5 (OJ L 68, 26.2.2021, p. 170).










12zzzzzzx.



32021 R 0348: Commission Implementing Regulation (EU) 2021/348 of 25 February 2021 approving carbendazim as an existing active substance for use in biocidal products of product-types 7 and 10 (OJ L 68, 26.2.2021, p. 174).










12zzzzzzy.



32021 D 0327: Commission Implementing Decision (EU) 2021/327 of 23 February 2021 postponing the expiry date of approval of metofluthrin for use in biocidal products of product-type 18 (OJ L 64, 24.2.2021, p. 10).










12zzzzzzz.



32021 D 0333: Commission Implementing Decision (EU) 2021/333 of 24 February 2021 postponing the expiry date of approval of alphachloralose for use in biocidal products of product-type 14 (OJ L 65, 25.2.2021, p. 58).










12zzzzzzza.



32021 D 0354: Commission Implementing Decision (EU) 2021/354 of 25 February 2021 postponing the expiry date of approval of propiconazole for use in biocidal products of product-type 8 (OJ L 68, 26.2.2021, p. 219).’






Article 2
The texts of Implementing Regulations (EU) 2021/345, (EU) 2021/347 and (EU) 2021/348 and Implementing Decisions (EU) 2021/327, (EU) 2021/333 and (EU) 2021/354 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.


Article 3
This Decision shall enter into force on 30 October 2021, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).


Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.




Done at Brussels, 29 October 2021.


For the EEA Joint Committee


The President

Rolf Einar FIFE
            





(1)  
            OJ L 68, 26.2.2021, p. 163.

(2)  
            OJ L 68, 26.2.2021, p. 170.

(3)  
            OJ L 68, 26.2.2021, p. 174.

(4)  
            OJ L 64, 24.2.2021, p. 10.

(5)  
            OJ L 65, 25.2.2021, p. 58.

(6)  
            OJ L 68, 26.2.2021, p. 219.

(*1)  No constitutional requirements indicated.


ELI: http://data.europa.eu/eli/dec/2024/537/oj
ISSN 1977-0677 (electronic edition)